Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRalpha, VEGFR2, FGFR1, and Src, respectively[1].
Molecular Weight:
532.56
Purity:
99.67
CAS Number:
[943319-70-8]
Formula:
C29H27F3N6O
Target:
Autophagy,Bcr-Abl,FGFR,PDGFR,Src,VEGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
